CLINICAL TRIALS PROFILE FOR ROSUVASTATIN CALCIUM
✉ Email this page to a colleague
All Clinical Trials for ROSUVASTATIN CALCIUM
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00214630 ↗ | LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes | Completed | AstraZeneca | Phase 3 | 2003-12-01 | Comparison of rosuvastatin and atorvastatin in subjects with acute coronary syndromes |
NCT00225589 ↗ | A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR) | Completed | AstraZeneca | Phase 3 | 2002-08-01 | The purpose of this trial is to see if rosuvastatin will be effective in decreasing the thickness of the walls of the arteries in the neck for people who already have some evidence of thickening of these walls. |
NCT00240318 ↗ | A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID) | Completed | AstraZeneca | Phase 3 | 2002-11-01 | The purpose of this study is to see if 40 mg of rosuvastatin taken daily will reduce the atherosclerosis (fatty deposits) in your arteries |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ROSUVASTATIN CALCIUM
Condition Name
Clinical Trial Locations for ROSUVASTATIN CALCIUM
Trials by Country
Clinical Trial Progress for ROSUVASTATIN CALCIUM
Clinical Trial Phase
Clinical Trial Sponsors for ROSUVASTATIN CALCIUM
Sponsor Name